| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| ChiCTR2500102712 |
A Phase II Trial of adjuvant moderate hypofractionation after radical prostatectomy Chinese PLA General Hospital |
prostate cancer |
Therapy Study |
Premarket |
2025-07-08 | 317 | Patient list |
| ChiCTR2400089257 |
Efficacy and safety of tenofovir alafenamide in CHB patients with low-level viraemia The Fifth Medical Center of Chinese PLA General Hospital |
|
Diagnostic Accuracy Test |
Post-market |
2025-01-28 | 462 | Patient list |
| ChiCTR2400092633 |
the First Medical Centre, Chinese PLA General Hospital, Beijing 100853, China. |
Intracranial Atherosclerotic Stenosis |
Therapy Study |
Premarket |
2024-12-14 | 465 | Patient list |
| ChiCTR2400089649 |
Chinese PLA General Hospital |
|
Cause Study |
Post-market |
2024-10-06 | 729 | Patient list |
| ChiCTR2400089772 |
Chinese PLA General Hospital |
|
Prognostic Study |
Post-market |
2024-10-06 | 679 | Patient list |
| ChiCTR2400089441 |
Chinese PLA General Hospital |
|
Cause Study |
Post-market |
2024-04-25 | 785 | Patient list |
| ChiCTR2400089467 |
Chinese PLA General Hospital |
|
Diagnostic Accuracy Test |
Premarket |
2024-04-25 | 701 | Patient list |
| chiCTR2300078994 |
Study on a universal comprehensive intervention program for vascular diseases in the elderly Ethics Committee of Chinese PLA General Hospital |
|
|
|
2024-04-18 | 632 | Patient list |
| 待审核 |
Chinese PLA General Hospital |
|
Therapy Study |
Premarket |
2024-03-26 | 965 | Patient list |
| ChiCTR2300074761 |
Chinese PLA General Hospital |
|
|
|
2023-09-16 | 717 | Patient list |